2022-001809-50
A PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, 4-ARM
Pfizer Inc.·EU Clinical Trials RegisterOngoing
Study focus
- Disease/Condition
- Heart failure
Sponsor & location
- Primary sponsor
- Pfizer Inc.
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
Medical Conditions:
ICD-10 classifications
Heart failureHeart failure, unspecifiedCongestive heart failureHypertensive heart disease with (congestive) heart failureLeft ventricular failure
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2022-001809-50
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2022-001809-50 through Pure Global AI's free database. This phase not specified trial is sponsored by Pfizer Inc. and is currently Ongoing. The study focuses on Heart failure.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.